Arkolith/Insider Trading/XFOR/Form 4

Ragan Paula

President and CEO, DirectorX4 Pharmaceuticals, Inc (XFOR) · full profile →Form 4 · filed Nov 3, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$182K
Net Open-Market Flow
-$182K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 3, 2023Sell(S)40K$0.90$36K836K
Nov 1, 2023Sell(S)200K$0.73$146K876K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001628280-23-036796) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML